🦊/Companies

Nimble Therapeutics

Madison, US · Founded 2019 · Delaware corporation · 12 employees on LinkedIn · 1 known investors

Find your way into Nimble Therapeutics

124 people in our graph share verified history with the Nimble Therapeutics team — schools, employers, funds. One of them is your warm intro.

Jim Huntunlockedknows Jigar Patel · together at University of Notre Dame (overlapped)
×6knows the team · via University of Notre Dame
×5knows the team · via AbbVie

A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas. The page content appears to redirect to AbbVie, and provides limited specific information about Nimble Therapeutics itself.

Founders & leadership

JPJigar Patel
Jigar PatelinCEOJigar Patel is an executive in the biotechnology industry with experience in business development, drug discovery, and genomics. He serves as an executive officer and director at Nimble Therapeutics, a biopharmaceutical company developing immunology-based medicines.

Board

RHRob Hart
Rob HartinFounding Investor, Director2019–2025Partner at Telegraph Hill Partners
DLDeval Lashkari
Deval LashkariinDirector Board Of DirectorsSenior Partner at Telegraph Hill Partners

Investors · 1

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2019

$10MraisedApr 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jigar PatelExecutive Officer, Director
  • Rob HartDirector
  • Deval LashkariDirector
Offering amount
$10M
Amount sold
$10M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does Nimble Therapeutics do?
A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas. The page content appears to redirect to AbbVie, and provides limited specific information about Nimble Therapeutics itself.
Who are Nimble Therapeutics's investors?
Nimble Therapeutics's investors include Telegraph Hill Partners.
How much funding has Nimble Therapeutics raised?
Nimble Therapeutics has disclosed $10M raised across 1 round.
Where is Nimble Therapeutics headquartered?
Nimble Therapeutics is headquartered in Madison, US.